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Background: The longitudinal course of multiple symptom domains in adolescents treated for major depression is
not known. Revealing the temporal course of general and specific psychopathology factors, including potential
differences between psychotherapies, may aid therapeutic decision-making.Methods: Participants were adolescents
with major depressive disorder (aged 11–17; 75% female; N = 465) who were part of the IMPACT trial, a randomized
controlled trial comparing cognitive behavioral therapy, short-term psychoanalytic psychotherapy, and brief
psychosocial intervention. Self-reported symptoms at baseline and 6, 12, 36, 52, and 86 weeks postrandomization
were analyzed with bifactor modeling. Results: General psychopathology factor scores decreased across treatment
and one-year follow-up. Specific melancholic features and depressive cognitions factors decreased from baseline to
6 weeks. Conduct problems decreased across treatment and follow-up. Anxiety increased by 6 weeks and then
reverted to baseline levels. Obsessions–compulsions did not change. Changes in general and specific factors were not
significantly different between the three psychotherapies during treatment. During follow-up, however, conduct
problems decreased more in brief psychosocial intervention versus cognitive behavioral therapy (1.02, 95% Bayes
credible interval 0.25, 1.96), but not versus short-term psychoanalytic psychotherapy. Conclusions: The clinical
response signature in this trial is best revealed by rapid reductions in depression symptoms and general
psychopathology. Protracted improvements in general psychopathology and conduct problems subsequently occur.
Psychosocial treatments for adolescent depression have comparable effects on general and specific psychopathology,
although a psychoeducational, goal-focused approach may be indicated for youth with comorbid conduct problems.
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Introduction
There is increasing empirical support for a general
psychopathology factor that accounts for shared
variance in diverse symptoms of mental illness
(Caspi et al., 2014; Caspi & Moffitt, 2018; Castel-
lanos-Ryan et al., 2016; Laceulle, Vollebergh, &
Ormel, 2015). Evidence for this general factor runs
counter to most current clinical practices, which
often focus on categorical diagnosis and associated
narrow-band questionnaires, and presumes disor-
der-specific interventions (Caspi & Moffitt, 2018;
Hopwood et al., 2019; Messer & Wampold, 2006;
Rodriguez-Seijas, Eaton, & Krueger, 2015). However,
treatments often reduce symptoms in comorbid
domains not explicitly targeted (Hilton et al., 2013;
Weisz, McCarty, & Valeri, 2006), suggesting that
interventions may decrease psychiatric symptoms
overall, rather than those within a single category of
psychopathology (Constantinou et al., 2019;
Hopwood et al., 2019). We examined change in
general and specific psychopathology factors among
adolescents participating in psychosocial treatments
for major depression in the IMPACT trial (Goodyer
et al., 2017b, 2011). Use of the general psy-
chopathology factor as an outcome variable has
potential to provide new insights into symptom
patterns over time and whether these patterns vary
for different psychotherapies.
General psychopathology factor
The concept of a general factor of psychopathology
was popularized by Caspi et al. (2014), building on
evidence of overall internalizing and externalizing
dimensions of psychopathology (Achenbach & Edel-
brock, 1978; Lahey, Van Hulle, Singh, Waldman, &
Rathouz, 2011). The general, ‘p’, factor is dimen-
sional and empirically derived using bifactor model-
ing and captures shared variance in symptoms
across the spectrum of psychopathology (Kotov
et al., 2017; Krueger et al., 2018). Specific factors
with variance unique to each symptom domain, not
Conflict of interest statement: See Acknowledgements for full
disclosures.
© 2020 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and
Adolescent Mental Health.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and
reproduction in anymedium, provided the original work is properly cited and is not used for commercial purposes.
Journal of Child Psychology and Psychiatry **:* (2020), pp **–** doi:10.1111/jcpp.13194
PFI_12mmX178mm.pdf + eps format
accounted for by the general factor, are also
identified.
The p factor appears to reflect an overall liability to
psychopathology, which may be explained by under-
lying emotion dysregulation, negative emotionality,
and unwanted irrational thoughts (Carver, Johnson,
& Timpano, 2017; Caspi et al., 2014; Caspi & Moffitt,
2018). Analyses in clinic and community samples
support the reliability and validity of the general
psychopathology factor (Carragher et al., 2016;
Haltigan et al., 2018; Patalay et al., 2015; Waldman,
Poore, van Hulle, Rathouz, & Lahey, 2016). Research
on the general factor as a treatment outcome mea-
sure is now needed to understand treatment effec-
tiveness in the context of empirically driven,
dimensional models of psychopathology (Caspi &
Moffitt, 2018; Hopwood et al., 2019).
IMPACT trial
The IMPACT trial was a multisite, randomized prag-
matic superiority effectiveness trial comparing three
structured psychosocial therapies for adolescents
with a primary diagnosis of major depressive disor-
der (Goodyer et al., 2017b, 2011): cognitive behav-
ioral therapy (CBT), focused on behavioral activation
and identifying and modifying information process-
ing biases; short-term psychoanalytic psychother-
apy (STPP), focused on giving meaning to the
varieties of the client’s emotional experiences and
addressing difficulties in the context of the develop-
mental tasks of adolescence (Cregeen, Hughes, Mid-
gley, Rhode, & Rustin, 2017); and brief psychosocial
intervention (BPI), a goal-oriented therapy focused
on psychoeducation about depression and increas-
ing positive activities (Goodyer et al., 2017a).
CBT, STPP, and BPI were associated with similar
decreases in depression and psychosocial impair-
ment at the end of the treatment (36 weeks) and one-
year follow-up in the IMPACT trial (Goodyer et al.,
2017b). In contrast, secondary outcomes of anxiety,
obsessions/compulsions, and antisocial behaviors
were significantly lower at the end of the treatment,
in favor of the psychological therapies (CBT + STPP)
compared to BPI, but no such difference was sus-
tained at the conclusion of the study. This suggests
BPI may have similar effects as the other therapies on
depression symptoms, but psychological therapies
such as CBT and STPP may have more immediate
benefits for comorbid symptoms. The inclusion of
nondepressive symptoms may make the general fac-
tor more sensitive to change and relevant to patients’
experience. Here we speculate that the psychological
therapies may bemore effective (or efficient) at reduc-
ing a general factor score more rapidly than BPI.
The results of the IMPACT trial suggested that a
dimensional, transdiagnostic analysis may enhance
understanding of differences in treatment response.
Narrow-band (i.e., total scores within a symptom
domain) measures of depression, anxiety,
obsessions/compulsions, and conduct problems
showed similar decreases across treatment and
follow-up, suggesting a common course of nonde-
pressive and depressive symptoms (Goodyer et al.,
2017b). The self-report depression and anxiety
scales used in the IMPACT trial have also previously
shown a good fit for a latent bifactor model in
community adolescents (n = 1,159), with a general
factor and specific melancholic, cognitive, and anx-
iety factors (Brodbeck et al., 2014). A general
psychopathology factor may therefore explain the
transdiagnostic decline in symptoms in the IMPACT
trial. Further, examining the longitudinal course of
general and specific factors may provide novel infor-
mation on change during treatment and follow-up
not seen using narrow-band instruments. Here we
speculate that specific factors have prognostic valid-
ity and are not merely carrying redundant variance.
Present study
Use of the general psychopathology factor as an
outcome in clinical trials is limited and has not
focused on youth with major depression (Constanti-
nou et al., 2019; Wade, Fox, Zeanah, & Nelson,
2018). The present study examines change in gen-
eral and specific psychopathology factors among
adolescents with a primary diagnosis of major
depression receiving one of three psychosocial inter-
ventions: CBT, STPP, and a reference standardized
care as usual treatment, BPI. Considering prior
findings from the IMPACT trial (Goodyer et al.,
2017b) and analyses of the general factor in other
clinical trials (Constantinou et al., 2019; Wade et al.,
2018), we hypothesize that:
1. Symptom reductions will be reflected in
decreases in the general factor across treatment
and follow-up.
2. Specific factors will show different patterns of
change compared to the general factor, with
greater reductions early in treatment and mini-
mal subsequent change over follow-up.
3. The established psychological therapies (CBT,
STPP) will be associated with greater reductions
compared with BPI in all factors during the
treatment phase but not during follow-up.
Methods
We analyzed data from the IMPACT trial (Goodyer et al., 2017b,
2017a, 2011) collected at baseline and nominal 6, 12, 36, 52,
and 86 weeks postrandomization (for full protocol, see Good-
yer et al., 2011). Participating adolescents were randomly
assigned, between June 2010 and January 2013, to receive
CBT (n = 154), STPP (n = 156), or BPI (n = 155; for CONSORT
diagram, see Goodyer et al., (2017a, 2017b); see Table S1 for
baseline characteristics by treatment group). There were no
significant differences in selective serotonin reuptake inhibitor
(SSRI) prescribing between treatments and no effect of SSRI
prescribing on the primary outcome of self-reported depressive
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symptoms (Goodyer et al., 2017b). Mean treatment length was
24.9 weeks (CBT), 27.9 weeks (STPP), and 27.5 weeks (BPI).
Participants attended a median of nine therapy sessions
(range = 0–43; BPI median = 6, IQR, 4–11; CBT median = 9,
IQR 5–14; STPP median = 11, IQR 5–23).
Study population
Participants were recruited from 15 specialized outpatient
mental health clinics in three urban or rural regions in
England. All participants had an existing DSM-IV diagnosis
of moderate to severe major depressive disorder (Goodyer et al.,
2017b, 2011). A total of 465 adolescents aged 11–17
(M = 15 years; 75% female; 85% self-reported their ethnicity
as White) were included in the present study (470 randomized;
5 withdrew consent). Comorbidity was relatively common, with
48% of participants meeting DSM-IV criteria for one or more
comorbid disorders.
Ethical considerations
All participating youth and parents provided informed consent
to participate in the IMPACT trial. All study procedures were
approved by the Cambridgeshire 2 Research Ethics
Committee.
Measures
Adolescent self-reports, completed at six time points, were
used: (a) the Mood and Feelings Questionnaire (Costello &
Angold, 1988), a 33-item measure of depression symptoms; (b)
the Revised Children’s Manifest Anxiety Scale (Reynolds &
Paget, 1981; Reynolds & Richmond, 1978), a 28-item anxiety
questionnaire; (c) the short Leyton Obsessional Inventory
(Bamber, Tamplin, Park, Kyte, & Goodyer, 2002), an 11-item
measure of obsessions and compulsions; and (d) an 11-item
antisocial behavior checklist derived from DSM-IV criteria for
conduct disorder (Goodyer et al., 2011). All items were rated on
a 4-point scale (never, sometimes, mostly, or almost always).
Responses of mostly and almost always were collapsed (Good-
yer et al., 2017b). Mean self- and parent ratings on the Health
of the Nation Outcome Scales for Children and Adolescents
(HoNOSCA; Gowers et al., 1999; Gowers, Levine, Bailey-
Rogers, Shore, & Burhouse, 2002) at each time point were
used to measure overall symptom burden and impairment.
Statistical analysis
Analyses were carried out using Mplus 8.2 (Muthen & Muthen,
2017) with Bayesian methods equivalent to full information
maximum likelihood (Muthen & Muthen, 2017) to handle
missing data. Results were considered significant if the 95%
Bayes credibility interval did not include zero. We used
exploratory factor analysis of baseline self-reported psy-
chopathology items to identify their factor structure (see
Appendix S1, Tables S2 and S3), which we then used in a
multilevel confirmatory factor analysis (CFA) using data from
all time points comparing: unidimensional, correlated factors,
and orthogonal bifactor (with specific factors uncorrelated; see
Figure 1 & Appendix S1) models. We calculated model-based
reliability coefficients for general and specific factors from the
orthogonal bifactor model (see Appendix S1; Dueber, 2017)
Using data from all time points, we regressed parent- and self-
reported HoNOSCA mean scores on factors from the orthogo-
nal bifactor model to examine their convergent validity. We
regressed the factors on dummy-coded time points (Wright,
Hopwood, Skodol, & Morey, 2016) to examine change over time
and compared scores between adjacent time points (see
Appendix S1). We used treatment-specific variables in a
multilevel CFA to compare change in general and specific
factors in CBT, STPP, and BPI (see Appendix S1).
Results
Multilevel CFA
Both the orthogonal bifactor model (Figure 1),
including a general factor and five specific factors
(melancholic features, depressive cognitions, anxi-
ety, obsessions–compulsions, and conduct prob-
lems), and the correlated factor model fit well,
although the orthogonal bifactor model’s fit was
superior (see Table 1, Appendix S1 and Table S4).
In the orthogonal bifactor model, the general
factor, along with the conduct problems and obses-
sions–compulsions specific factors, demonstrated
adequate reliability, whereas evidence was mixed
for the depressive cognitions factor, and reliability
scores were somewhat lower for the melancholic
features and anxiety specific factors (see
Appendix S1). Higher general factor and specific
conduct problems and melancholic features factor
scores were associated with greater symptom burden
and impairment across time. Higher depressive
cognitions factor scores were associated with more
self- but not parent-reported symptom burden and
impairment. Anxiety and obsessions–compulsions
factor scores were inversely related to symptom
burden and impairment (see Table 2 and Table S5
for further analyses).
Change over time
General factor scores decreased significantly
between time points from baseline to 52 weeks (see
Figure 2 and Table S6). Specific melancholic fea-
tures, depressive cognitions, and conduct problems
factors decreased significantly from baseline to
6 weeks but did not otherwise change significantly
between adjacent time points. In supplementary
analyses, conduct problems further decreased
across treatment and follow-up, despite nonsignifi-
cant differences between adjacent time points (see
Table S7 and Appendix S1). In contrast, the anxiety
factor increased significantly from baseline to
6 weeks and then decreased significantly between
12 and 36 weeks. Anxiety scores at 6 and 12 weeks
were significantly higher than baseline but did not
differ from baseline at subsequent time points. There
was no change in obsessions–compulsions factor
scores. In preliminary analyses, there were no
differences in change over time by participant sex
or geographic region (see Tables S8 and S9).
Treatment effects
CBT and STPP, and STPP and BPI, did not differ in
their associations with changes in factor scores
across time (see Figure 3, and Tables S10 and
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S11). However, there was a significantly larger
decrease in conduct problems from 36 to 52 weeks
(i.e., post-treatment phase) in BPI compared with
CBT, although not compared with STPP. No other
treatment differences were significant. An analysis
comparing BPI versus [CBT + STPP] showed similar
results (see Appendix S1 and Table S12).
Discussion
To our knowledge, this study is the first to examine
the effects of psychosocial therapy on general and
specific psychopathology factors in adolescents
presenting with major depression and comorbid
conditions. A latent bifactor model with five specific
factors and a general psychopathology factor fitted
the data well. Consistent with our first hypothesis,
the general p factor (containing variance from all 37
psychopathology items) decreased significantly
across treatment and one-year follow-up. In con-
trast, in line with our second hypothesis, specific
factors showed less consistent decreases over time.
For example, specific melancholic features and
depressive cognitions factors decreased only during
Figure 1 Orthogonal bifactor model
Table 1 Fit statistics for multilevel confirmatory factor analysis across six time points
Model FP v2 RMSEA CFI BICa DBICa
Unidimensional 111 16,723.09 .110 .866 114,936.84 –
Five correlated factors 121 4,636.37 .056 .967 109,178.53 5,758.31
Orthogonal bifactor 148 3,134.42 .045 .979 108,386.26 797.27
BIC, Bayesian information criterion; CFI, comparative fit index; FP, free parameters; RMSEA, root mean squared error of
approximation.
aBIC values were obtained by rerunning the analysis with the maximum likelihood estimator. Change in BIC is calculated from the
model in the line above.
© 2020 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
4 Madison Aitken et al.
the initial weeks of therapy, whereas anxiety factor
scores initially increased and then returned to
baseline, and conduct problems factor scores con-
tinued to decrease across treatment and follow-up.
The course of the general and specific factors
reveals novel insights into change across treatment
and follow-up not evident when using the sum
scores from each of the narrow-band domain
measures reported in the original study (Goodyer
et al., 2017b).
Table 2 Multivariate regression of symptom burden and impairment ratings on general and specific factors
Variable Estimate Posterior SD p
95% Bayes CI
SignificanceLower 2.5% Upper 2.5%
Self-reported impairment
General factor 0.675 0.015 <.001 0.644 0.705 *
Melancholic features 0.159 0.028 <.001 0.104 0.213 *
Depressive cognitions 0.091 0.025 <.001 0.042 0.139 *
Anxiety 0.053 0.024 .015 0.100 0.005 *
Obsessions–compulsions 0.056 0.020 .003 0.096 0.016 *
Conduct problems 0.184 0.022 <.001 0.141 0.227 *
Parent-reported impairment
General factor 0.480 0.027 <.001 0.426 0.531 *
Melancholic features 0.096 0.040 .009 0.017 0.173 *
Depressive cognitions 0.039 0.037 .146 0.034 0.112
Anxiety 0.099 0.038 .005 0.173 0.024 *
Obsessions–compulsions 0.072 0.032 .012 0.134 0.010 *
Conduct problems 0.213 0.033 <.001 0.148 0.277 *
Standardized estimates. CI = credibility interval. One-tailed p values based on the posterior distribution can be interpreted as the
proportion of the posterior distribution that is below zero (or, for negative estimates, above zero).
*95% Bayes credibility interval does not contain 0.
Figure 2 General and specific factor scores across treatment and follow-up. Error bars represent the 95% Bayes credibility interval. Factors
are derived from orthogonal bifactor modeling, in which each item loads on the general p factor has its remaining variance accounted
for by one of the five specific factors
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The general psychopathology factor and the speci-
fic conduct problems factor showed continued
decreases across treatment and into follow-up.
These continued decreases across time suggest that
general psychopathology and specific conduct prob-
lems are the two factors that may be most responsive
to therapy, including further improvements once
therapy has ended. In the main IMPACT trial anal-
ysis (Goodyer et al., 2017b), significant decreases in
anxiety, depression, obsessions–compulsions, and
antisocial behavior were noted. Previous randomized
controlled trials of psychotherapy for depression
have also demonstrated improvements in comorbid
symptom domains, including anxiety, attention-
deficit/hyperactivity disorder, and conduct prob-
lems (Asarnow et al., 2009; Hilton et al., 2013).
Our results suggest that decreases in these various
symptom domains can be best understood as overall
decreases in psychopathology, rather than improve-
ments in discrete symptom areas. These broad
decreases in psychopathology may be attributed to
improvements in transdiagnostic processes believed
to underlie the general psychopathology factor, such
as negative emotionality, emotion dysregulation, or
unwanted irrational thoughts (Asarnow et al., 2009;
Carver et al., 2017; Caspi et al., 2014; Caspi &
Moffitt, 2018). The present findings parallel those of
longitudinal and intervention studies, which have
reported a steady decrease in general psychopathol-
ogy (Constantinou et al., 2019; Wade et al., 2018;
Wright et al., 2016). Decreases in specific conduct
problems during and following psychosocial treat-
ment have also been reported in institutionalized
children placed in foster care (Wade et al., 2018), and
in adolescents being treated for conduct problems
(Constantinou et al., 2019). The marked decrease in
Figure 3 Change in general and specific factor scores by treatment type. BPI, brief psychosocial intervention; CBT, cognitive behavioral
therapy; and STPP, short-term psychoanalytical psychotherapy. Error bars represent the 95% Bayes credibility interval. Factors are derived
from orthogonal bifactor modeling, in which each item loads on the general p factor has its remaining variance accounted for by one of
the five specific factors
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conduct problems in our model is notable in com-
parison with results of studies using narrow-band
domain measures, which have found inconsistent
effects on conduct problems in adolescents being
treated for depression (Goodyer et al., 2017b; Weisz
et al., 2006).
We hypothesized that specific factors might differ
in the amount they change during treatment and
follow-up. We note the rapid decrease from baseline
to 6 weeks for general psychopathology and some
specific factors (melancholic, depressive cognitions,
and conduct): This may index a mechanism common
to all the therapies, such as feeling understood or
instilling a sense of hope. The lack of any further
significant change in melancholic and depressive
cognitions factors suggests that their subsequent
levels may index more trait-like features or compo-
nents less responsive to psychological intervention.
Higher melancholic features and depressive cogni-
tions scores were also associated with greater symp-
tom burden and impairment, in line with evidence
that specific internalizing, independent of the gen-
eral factor, is related to psychosocial impairment
severity (Haltigan et al., 2018). Thus, even after
structured psychotherapy, adolescents may experi-
ence residual symptoms specific to melancholy (e.g.,
anhedonia, fatigue) and depressive thinking that are
associated with ongoing impairment. Further
research is needed to determine the longitudinal
relevance of persistent melancholy and depressive
cognitions to treatment response and relapse. Ther-
apies that better address residual depressive symp-
toms are also needed.
In contrast, the specific anxiety factor increased
from baseline to 6 weeks and then decreased to
baseline levels by 36 weeks, marking the end of the
treatment phase, consistent with evidence from
previous bifactor modeling of an increase in speci-
fic anxiety with treatment onset (Constantinou
et al., 2019). This pattern may reflect the potential
for therapy to initially increase anxiety, followed by
eventually becoming more comfortable with the
experience. The published results of the IMPACT
trial and other trials using narrow-band domain
measures have not captured this unique symptom
course, instead showing consistent decreases in
anxiety across treatment (Goodyer et al., 2017b;
Kerns, Read, Klugman, & Kendall, 2013; Young
et al., 2012). The specific anxiety factor derived
from bifactor modeling, a pure index of anxiety
once overall psychopathology has been controlled,
may therefore represent a novel and potentially
more precise aspect of anxiety symptomatology not
measured in previous clinical trials. The specific
anxiety factor was related to lower levels of symp-
tom burden/impairment in the present study. Of
note, this is consistent with some previous evi-
dence of an inverse association between the inter-
nalizing factor derived through bifactor modeling
and impairment (Caspi et al., 2014; Lahey et al.,
2015). One possible interpretation is that specific
anxiety symptoms, net of overall psychopathology,
may not require further intervention in adolescents
who have received a successful structured course
of psychotherapy for depression and may even be
adaptive. However, as it is also possible that this
finding may be artefactual, further research using
a broader set of anxiety items and a more com-
prehensive measure of function is needed to con-
firm this suggestion.
Interestingly, there was no statistically significant
change in the specific obsessions–compulsions fac-
tor over time. We speculate that obsessions and
compulsions, at least those indexed by the current
specific factor, are unlikely to contribute substan-
tially to treatment response or time to recovery.
Indeed, the specific obsessions–compulsions factor
was inversely related to symptom burden and
impairment as rated by youth and their parents,
consistent with previous evidence from bifactor
modeling (Laceulle, Chung, Vollebergh, & Ormel,
2019). As with the anxiety specific factor, this
negative association may have been due to this
factor being adaptive or may have been artefactual,
and needs further investigation. Further analyses of
treatment outcomes using bifactor modeling, includ-
ing different psychopathology measures, may
increase our understanding of how various therapies
are associated with changes in general and specific
aspects of psychopathology (Caspi & Moffitt, 2018).
When we examined the pattern of scores across
time by therapy type, the results were not consistent
with our third hypothesis: Patients receiving estab-
lished psychological treatments (CBT, STPP) did not
show greater reductions in any factor during the
treatment phase compared to those receiving BPI.
Changes in general and specific factor scores were
comparable for the three therapies during the treat-
ment phase. The original IMPACT trial reported no
superiority effects for established psychological
treatments compared with BPI. The authors specu-
lated that the comparable results of the three ther-
apies may be explained by either: a) similar
mechanisms underpinning therapeutic response
(other than time itself), often referred to as ‘common
factors’ (Messer & Wampold, 2006; Wampold, 2015);
or b) the three therapies having specific mechanisms
that operate to bring about the same observed end
points but by different therapeutic routes (equifinal-
ity; Calderon et al., 2019; Goodyer et al., 2017b;
Midgley et al., 2018). Bifactor modeling provides
some added value to the second of these suggestions,
noting that BPI is associated with an additional
decline in conduct factor scores post-treatment
compared to CBT. This may index a unique advan-
tage of BPI over CBT (but not STPP) for major
depression cases with high baseline conduct symp-
toms. Perhaps, the greater emphasis on ameliorating
peer and family relationships and school function-
ing, both of which predict less antisocial behavior
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(Dishion, Patterson, Stoolmiller, & Skinner, 1991),
or more liaison with carers and agencies, con-
tributed to continued decreases in conduct problems
in BPI compared to CBT; although it is notable that
STPP, which is not traditionally viewed as a treat-
ment for conduct disorder, also demonstrated a
decline in conduct factor scores, possibly due to
the fact that it focuses on the emotional difficulties
that may underlie conduct problems. If these find-
ings are replicated, this would be the first suggestion
that clinicians might be able to personalize treat-
ment for depressed adolescents based on their
conduct problem severity.
Limitations
Several limitations of the current study should be
noted. First, in terms of the measures used, the
items in our analysis were identified through an
exploratory factor analysis of baseline data and did
not include social anxiety, impulsivity, or executive
dysfunction. In addition, given the self-report nature
of our data and the depressive cognitions items
having a common stem, shared method variance
may have increased associations between items.
Although representative of a well-fitting factor struc-
ture, the items may also not be those most sensitive
to intervention. In addition, measures were not
always administered precisely at the given number
of weeks planned; therefore, our results should not
be used to make specific determinations about the
number of weeks at which change may be observed.
Second, reliabilities were somewhat low for the
melancholic features and anxiety specific factors;
therefore, it is important not to overinterpret the
meaning of these specific factors. Third, around 30%
of all participants in each group took a SSRI med-
ication during the trial, and our analysis did not
allow for an examination of medication onset effects.
Future research, including randomized controlled
trials, is needed to examine the effect of SSRIs on
general and specific psychopathology factors.
Finally, further validity analyses using other crite-
rion measures, including objective and/or biological
indicators, are needed. The current study also has
many strengths, including a relatively large clinical
sample of adolescents, multiple measurement points
during treatment and follow-up, random assign-
ment, and the ability to compare three types of
structured psychotherapy delivered in routine, free
to access, clinical practice.
Conclusion
In a recent editorial evaluating the state of the
science regarding the general psychopathology fac-
tor, Ronald asked: ‘Instead of treating specific
symptoms, or disorders, should we treat p?’ (Ron-
ald, 2019, p. 499). The present results suggest that
perhaps we already are. With the emphasis on
manualized, disorder-specific therapies over the
past three decades (Forbes, Rapee, & Krueger,
2019; Roy-Byrne, 2017), further research in other
samples will be important to understand the extent
to which evidence-based interventions may have
broad effects on general psychopathology (Hopwood
et al., 2019). Future investigations of change in
general and specific psychopathology factors with
modular and transdiagnostic therapy approaches
are also needed (Bilek & Ehrenreich-May, 2012;
Chorpita & Weisz, 2009; Chorpita et al., 2013;
Ehrenreich-May et al., 2017). Similarly, investiga-
tions of transdiagnostic prevention programs with
the potential for broad effects on psychopathology
may prove especially useful (Forbes et al., 2019).
Additionally, the potential importance of specific
factors in bifactor models of symptom change dur-
ing treatment not observed using traditional, disor-
der-specific, measurement approaches should not
be overlooked as these may aid personalized treat-
ment decision-making.
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Key points
 Evidence of the reliability and validity of the general psychopathology, ‘p’, factor, has accumulated in recent
years.
 This study provides novel information on how three types of psychotherapy influence general and specific
aspects of psychopathology.
 General factor and specific conduct problems factor scores decrease across treatment and follow-up, whereas
melancholic and depressive cognitions decrease only in the initial 6 weeks.
 Longitudinal courses of general and specific factors are similar across therapies, although conduct problems
decrease more post-therapy after brief psychosocial intervention than cognitive behavioral therapy, but not
short-term psychoanalytic psychotherapy.
 Bifactor modeling reveals symptom changes not observed using domain sum scores, including differences
that may aid selection of psychotherapy for depressed adolescents.
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